ENGLISH
|
HINDI
APPS
iPhone
|
iPad
|
BlackBerry
|
Android
Nokia
Windows
Network18
Quotes
Quotes
NAVs
News
Messages
People
Notices
Videos
All
FEEDBACK
Facebook
Follow @moneycontrolcom on Twitter
CNBC TV 18
moneycontrol
News
Markets
Mutual Funds
IPO
Commodities
Wealth
Portfolio
Messages
My TV
Tax
Fixed Income
Property
SME
CNBC-TV18
Home
Business
General News
Market Trends
Stocks
Fund News
Personal Finance
Corporate Strategy
Lifestyle
Politics
Legal
Master Your Money
Share
>
Share
Tweet
Share on Tumblr
Felodipine Capsules
News »
latest
by relevance
Ranbaxy's net profit at USD 39mn (Rs 1530 mn), + 19%
Apr 22, 2008 at 15:30
Ranbaxy Laboratories Net Profit at USD 39 Mn (Rs 1,530 Mn), + 19%. Consolidated sales at USD 409 Mn, (Rs 16,231 Mn), records a growth of 15%.
Ranbaxy-AstraZeneca in deal for Esomeprazole patent
Apr 15, 2008 at 14:25
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that it has reached several agreements with AstraZeneca.
Ranbaxy's net profit at USD 39mn (Rs 1530 mn), + 19%
Apr 22, 2008 at 15:30
Ranbaxy Laboratories Net Profit at USD 39 Mn (Rs 1,530 Mn), + 19%. Consolidated sales at USD 409 Mn, (Rs 16,231 Mn), records a growth of 15%.
Ranbaxy-AstraZeneca in deal for Esomeprazole patent
Apr 15, 2008 at 14:25
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that it has reached several agreements with AstraZeneca.
Photos »
/
Follow moneycontrol.com
Facebook
Twitter
Google Plus
RSS
Wap SMS
SMS
Alert
iPad
iPhone
Blackberry
OVI
Android
Window
/ 
/
/